OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

Rhea-AI Summary

OraSure Technologies, Inc. (NASDAQ: OSUR) announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on May 26, 2021, at 2:00 PM EDT. The event will be webcast live, and a replay will be available for 14 days on OraSure's website. OraSure is known for its point-of-care diagnostic tests and specimen collection devices, playing a significant role in global health through its subsidiaries that offer a range of diagnostics and services.

BETHLEHEM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the UBS Global Healthcare Virtual Conference. The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT. The live webcast and a replay of the presentation can be accessed by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for 14 days. Alternatively, you can access the live webcast of the presentation here.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contacts:

Scott Gleason
SVP of IR and Corp. Communications
484-425-0588
sgleason@orasure.com

Jeanne Mell
VP Corporate Communications
484-353-1575
media@orasure.com
www.orasure.com

FAQ

When will Dr. Stephen S. Tang speak at the UBS Global Healthcare Virtual Conference?

Dr. Stephen S. Tang is scheduled to speak on May 26, 2021, at 2:00 PM EDT.

How can I watch the OraSure Technologies webcast?

You can watch the live webcast on OraSure Technologies' website, where a replay will also be available for 14 days.

What is the significance of the UBS Global Healthcare Virtual Conference for OSUR shareholders?

The conference provides a platform for Dr. Tang to discuss the company's strategic direction and innovations, which is important information for OSUR shareholders.

What does OraSure Technologies specialize in?

OraSure Technologies specializes in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory services.

Where can I find more information about OraSure Technologies?

More information about OraSure Technologies can be found on their official website at www.orasure.com.